Creative Planning’s Definium Therapeutics DFTX Stock Holding History

Creative Planning’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Buy	+6,906	New	+$171K	﹤0.01%	3509
2025 Q4	–	Sell	-11,909	Closed	-$140K	–	4032
2025 Q3	$140K	Sell	11,909 -54,188	-82%	-$505K	﹤0.01%	3597
2025 Q2	$429K	Buy	66,097 +1,655	+3%	+$10.9K	﹤0.01%	2605
2025 Q1	$377K	Buy	+64,442	New	+$462K	﹤0.01%	2558
2023 Q4	–	Sell	-218	Closed	-$683	–	2954
2023 Q3	$683	Buy	+218	New	+$896	﹤0.01%	2849
2022 Q3	–	Sell	-3,544	Closed	-$34K	–	2400
2022 Q2	$34K	Sell	3,544 -156	-4%	-$1.97K	﹤0.01%	2093
2022 Q1	$62K	Sell	3,700 -172	-4%	-$2.98K	﹤0.01%	2041
2021 Q4	$80K	Sell	3,872 -1,210	-24%	-$38.6K	﹤0.01%	1967
2021 Q3	$178K	Buy	5,082 +3,606	+244%	+$156K	﹤0.01%	1880
2021 Q2	$76K	Buy	+1,476	New	+$77.5K	﹤0.01%	1900

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Creative Planning's DFTX Position: Q2 2026 in Review

Creative Planning opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 6,906 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #3509 among its holdings. This is a return to the name: Creative Planning previously reported a position in DFTX as recently as Q3 2025.

Creative Planning first reported a position in DFTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $429K in Q2 2025. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Creative Planning held 6,906 shares of Definium Therapeutics worth $325K as of Q2 2026.
Definium Therapeutics was a new Creative Planning position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3509 holding.
Creative Planning first reported a position in Definium Therapeutics in Q2 2021 and has held it in 10 quarters since.
Creative Planning's Definium Therapeutics position peaked at $429K in Q2 2025.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.